首页> 美国卫生研究院文献>BMJ Open >Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis

【2h】

Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis

机译：剂量高的替莫唑胺/ 21/28天方案治疗伴发性胶质母细胞瘤的同时治疗调制性体温过高的临床和经济评估：一项两中心的德国队列研究的回顾性分析包括系统比较和疗效分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo assess the efficacy and cost-effectiveness of modulated electrohyperthermia (mEHT) concurrent to dose-dense temozolomide (ddTMZ) 21/28 days regimen versus ddTMZ 21/28 days alone in patients with recurrent glioblastoma (GBM).

机译：目的评估重度成胶质母细胞瘤（GBM）患者与剂量密集的替莫唑胺（ddTMZ）21/28天方案相对于ddTMZ 21/28天方案并发调制电热疗法（mEHT）的疗效和成本效益。

著录项

期刊名称 BMJ Open
作者
Sergey V Roussakow;
展开▼
作者单位

展开▼
年(卷),期 2017(7),11
年度 2017
页码 e017387
总页数 34
原文格式 PDF
正文语种
中图分类
关键词
recurrent glioblastoma modulated electro-hyperthermia (meht) oncothermia dose-dense temozolamide (ddtmz effect-to-treatment analysis (eta) cost-effectiveness analysis;

机译：复发性胶质母细胞瘤;调节性体温过高（meht）;体温升高;剂量密集的替莫唑胺（ddtmz）;疗效分析（eta）;成本效益分析;

相似文献

外文文献
中文文献

1. Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison [J] . Sergey V Roussakow BMJ Open . 2017,第11期

机译：联合剂量密集的替莫唑胺/ 21/28天方案治疗复发性胶质母细胞瘤的临床电热疗法的临床和经济评估：一项两中心的德国队列研究的回顾性分析，系统比较
2. A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma. [J] . Neyns B, Chaskis C, Joosens E, Cancer investigation . 2008,第3期

机译：多剂量替莫唑胺（28天中的21天）用于治疗复发性间变性星形细胞瘤或少细胞星形细胞瘤的多中心队列研究。
3. The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis [J] . Wei Wei, Chen Xin, Ma Ximeng, Journal of neuro-oncology. . 2015,第2期

机译：替莫唑胺各种剂量密集方案对复发性高级神经胶质瘤的疗效和安全性：荟萃分析的系统评价
4. Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas [O] . Vincent A van Vugt, David E Piccioni, Bradley D Brown, 2014

机译：回顾性分析成人成年恶性神经胶质瘤中替莫唑胺3天/ 11天停药的安全性和可行性
5. A phase II clinical trial evaluating the efficacy and safety of apatinib combined with dose-dense temozolomide in recurrent glioblastoma [O] . Y. Wang, R. Tao 2019

机译：AII期临床试验评估阿凡替尼将与剂量 - 密集的替塞替莫酮在复发胶质母细胞瘤中的疗效和安全性

Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis

摘要

著录项

相似文献

相关主题

期刊订阅